Literature DB >> 25547740

Impact of hypoalbuminemia, frailty, and body mass index on early prognosis in older patients (≥85 years) with ST-elevation myocardial infarction.

Yasumori Sujino1, Jun Tanno1, Shintaro Nakano2, Shuhei Funada1, Yoshie Hosoi1, Takaaki Senbonmatsu1, Shigeyuki Nishimura1.   

Abstract

BACKGROUND: The optimal treatment strategies for acute ST-elevation myocardial infarction (STEMI) in older patients are unclear because of the high risk of mortality in this population. Hypoalbuminemia, frailty, and body mass index (BMI) have been reported to worsen the prognosis of some older patients with cardiovascular disease, but the specific impact of these factors on the prognosis after STEMI is poorly understood. The aim of this study was to investigate the impact of these factors on early outcomes in patients aged ≥85 years with acute STEMI.
METHODS: Sixty-two consecutive eligible patients aged ≥85 years (mean age, 88.1±2.5 years; age range, 85-94 years; female, 41.9%; primary percutaneous coronary intervention, 67.7%) who were admitted to our hospital with STEMI were retrospectively reviewed. Baseline patient characteristics, echocardiographic, electrocardiographic, and laboratory findings, and the Canadian Study of Health and Aging Clinical Frailty Scale (CSHA-CFS) score were assessed. The primary endpoint was in-hospital mortality and the secondary endpoint was failure of discharge to home. Independent baseline variables with a p-value of <0.15 in the univariate analyses were included in the multivariate analyses.
RESULTS: Multivariate analysis identified a higher baseline serum troponin I level [p=0.046; odds ratio (OR): 1.02], lower baseline albumin level (p=0.035, OR: 0.16), and CSHA-CFS score ≥6 (p=0.028, OR: 6.38) as independent predictors of in-hospital mortality. Lower BMI (p<0.001, OR: 0.49) and CSHA-CFS frailty score ≥6 (p=0.002, OR: 16.69) were identified as independent predictors of failure of discharge to home.
CONCLUSIONS: These findings indicate that the serum albumin level, CSHA-CFS score, and BMI, in addition to serum troponin I level, have an impact on the early prognosis of older patients with STEMI.
Copyright © 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body mass index; Frailty; Hypoalbuminemia; In-hospital mortality; ST-elevation myocardial infarction

Mesh:

Substances:

Year:  2014        PMID: 25547740     DOI: 10.1016/j.jjcc.2014.12.001

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  18 in total

1.  Frailty is an independent prognostic marker in elderly patients with myocardial infarction.

Authors:  Gonzalo Luis Alonso Salinas; Marcelo Sanmartin; Marina Pascual Izco; Luis Miguel Rincon; Pablo Pastor Pueyo; Alvaro Marco Del Castillo; Alberto Garcia Guerrero; Pedro Caravaca Perez; Alejandro Recio-Mayoral; Asuncion Camino; Manuel Jimenez-Mena; José Luis Zamorano
Journal:  Clin Cardiol       Date:  2017-07-16       Impact factor: 2.882

2.  A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale.

Authors:  Puneeta Tandon; Navdeep Tangri; Lesley Thomas; Laura Zenith; Tahira Shaikh; Michelle Carbonneau; Mang Ma; Robert J Bailey; Saumya Jayakumar; Kelly W Burak; Juan G Abraldes; Amanda Brisebois; Thomas Ferguson; Sumit R Majumdar
Journal:  Am J Gastroenterol       Date:  2016-08-02       Impact factor: 10.864

Review 3.  Preoperative hypoalbuminemia in patients undergoing cardiac surgery: a meta-analysis.

Authors:  Ruoxin Xu; Meiqi Hao; Wei Zhou; Miaowen Liu; Yiping Wei; Jianjun Xu; Wenxiong Zhang
Journal:  Surg Today       Date:  2022-08-07       Impact factor: 2.540

4.  Comparison of the prognostic value of frailty assessment tools in patients aged ≥ 65 years hospitalized in a cardiac care unit with acute coronary syndrome.

Authors:  Wojciech Nowak; Ilona Kowalik; Małgorzata Kuzin; Agnieszka Krauze; Anna Mierzyńska; Ewa Sadowy; Kamil Marcinkiewicz; Janina Stępińska
Journal:  J Geriatr Cardiol       Date:  2022-05-28       Impact factor: 3.189

5.  Significance of frailty for predicting adverse clinical outcomes in different patient groups with specific medical conditions.

Authors:  Martin Ritt; Karl-Günter Gaßmann; Cornel Christian Sieber
Journal:  Z Gerontol Geriatr       Date:  2016-09-14       Impact factor: 1.281

6.  Accounting for frailty and multimorbidity when interpreting high-sensitivity troponin I tests in oldest old.

Authors:  Andrea Ticinesi; Antonio Nouvenne; Nicoletta Cerundolo; Beatrice Prati; Alberto Parise; Claudio Tana; Martina Rendo; Angela Guerra; Tiziana Meschi
Journal:  J Am Geriatr Soc       Date:  2021-11-18       Impact factor: 7.538

7.  Aggressive therapy with statins in elderly and malnourished patients with acute myocardial infarction: is the right time to change?

Authors:  Annamaria Mazzone; Umberto Paradossi; Sergio Berti; Giuseppina Basta
Journal:  J Geriatr Cardiol       Date:  2016-10       Impact factor: 3.327

8.  Prognostic nutritional index predicts clinical outcome in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Qing-Jie Chen; Hui-Juan Qu; Dong-Ze Li; Xiao-Mei Li; Jia-Jun Zhu; Yang Xiang; Lei Li; Yi-Tong Ma; Yi-Ning Yang
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

9.  Aged interleukin-10tm1Cgn chronically inflamed mice have substantially reduced fat mass, metabolic rate, and adipokines.

Authors:  Reyhan M Westbrook; Huan Le Yang; Jackie M Langdon; Cindy N Roy; Jin A Kim; Parichoy P Choudhury; Qian-Li Xue; Andrea di Francesco; Rafa de Cabo; Jeremy Walston
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

Review 10.  What do we know about frailty in the acute care setting? A scoping review.

Authors:  Olga Theou; Emma Squires; Kayla Mallery; Jacques S Lee; Sherri Fay; Judah Goldstein; Joshua J Armstrong; Kenneth Rockwood
Journal:  BMC Geriatr       Date:  2018-06-11       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.